Cover Image

Insulin-like peptide 5 (INSL5) positively correlates with anti-Müllerian hormone (AMH) in women with the polycystic ovary syndrome: a case-control study

Abstract Background Insulin-like peptide 5 (INSL5) is involved in both reproductive and metabolic processes in polycystic ovary syndrome (PCOS). This study aimed to evaluate the relationship between INSL5 and anti-Müllerian hormone (AMH). Methods A retrospective case-control study was conducted in...

Full description

Saved in:

Bibliographic Details
Main Authors:	Yijie Chen (Author), Miao Deng (Author), Zhaojing Chen (Author), Shuyang Han (Author), Jun Chen (Author), Hongyan Zhang (Author), Qianwen Wang (Author), Xuejing Jin (Author), Wenhua Liu (Author), Zhifen Zhang (Author)
Format:	Book
Published:	BMC, 2022-10-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Expression of insulin-like 3 (INSL3) and differential splicing of its receptor in the ovary of rhesus macaques
by: Jensen Jeffrey T, et al.
Published: (2010)

About the Anti-Müllerian Hormone (AMH) Uses in the Clinical Practice
by: Gustavo Arantes Rosa Maciel, et al.
Published: (2018)

Serum anti-Müllerian hormone (AMH) concentration during pregnancy: a longitudinal study
by: Sarah McCredie, et al.
Published: (2023)

Comparison of body mass index, anti-müllerian hormone and insulin resistance parameters among different phenotypes of polycystic ovary syndrome
by: Türkan Gürsu, et al.
Published: (2022)

New Insights into the Role of INSL-3 in the Development of Cryptorchidism
by: Alma-Raluca Lăptoiu, et al.
Published: (2023)

Anti Müllerian Hormone as a Predictor of Metabolic Syndrome in Polycystic Ovary Syndrome
by: Budi Wiweko, et al.
Published: (2017)

The role of anti-Mullerian hormone and other correlates in patients with polycystic ovary syndrome
by: Moaz O. Moursi, et al.
Published: (2023)

Discordances between follicle stimulating hormone (FSH) and anti-Müllerian hormone (AMH) in female infertility
by: Weghofer Andrea, et al.
Published: (2010)

Anti Müllerian Hormone (AMH) Level as Ovarian Reserve Marker before and after Cystectomy Laparotomy
by: Rosdiana Sahabuddin, et al.
Published: (2017)

The effects of metformin on anti-Müllerian hormone levels in patients with polycystic ovary syndrome: a systematic review and meta-analysis
by: Zhijiao Zhou, et al.
Published: (2023)

The Relationship Between Insulin Resistance and Obesity and Serum Anti-Mullerian Hormone Level in Chinese Women with Polycystic Ovary Syndrome: A Retrospective, Single-Center Cohort Study
by: Zhao H, et al.
Published: (2023)

Investigation of anti-mullerian hormone (AMH) level and ovarian response in infertile women with endometriosis in IVF cycles
by: Leili Safdarian, et al.
Published: (2018)

Metformin modifies plasma microbial-derived extracellular vesicles in polycystic ovary syndrome with insulin resistance
by: Liping Hu, et al.
Published: (2024)

Association between serum AMH levels and IVF/ICSI outcomes in patients with polycystic ovary syndrome: a systematic review and meta-analysis
by: Tianyi Yuwen, et al.
Published: (2023)

Iron stores and obesity are negatively associated with ovarian volume and anti-Müllerian hormone levels in women with polycystic ovary syndrome
by: Jehn-Hsiahn Yang, et al.
Published: (2015)

Abnormalities of early folliculogenesis and serum anti-Müllerian hormone in chinese patients with polycystic ovary syndrome
by: Juan Du, et al.
Published: (2021)

Correction: Metformin modifies plasma microbial-derived extracellular vesicles in polycystic ovary syndrome with insulin resistance
by: Liping Hu, et al.
Published: (2024)

Evaluation of Triglyceride Glucose Index and Homeostasis Model of Insulin Resistance in Patients with Polycystic Ovary Syndrome
by: Zheng Y, et al.
Published: (2022)

Age effect on in vitro fertilization pregnancy mediated by anti-Mullerian hormone (AMH) and modified by follicle stimulating hormone (FSH)
by: Han-Chih Hsieh, et al.
Published: (2020)

Diagnostic value of anti-Müllerian hormone combined with androgen-levels in Chinese patients with polycystic ovary syndrome
by: Lingling Jiang, et al.
Published: (2023)

Serum and follicular anti-Mullerian hormone levels in women with polycystic ovary syndrome (PCOS) under metformin
by: Falbo Angela, et al.
Published: (2010)

Accuracy of anti-Müllerian hormone and total follicles count to diagnose polycystic ovary syndrome in reproductive women
by: Thanyarat Wongwananuruk, et al.
Published: (2018)

Mangiferin ameliorates polycystic ovary syndrome in rats by modulating insulin resistance, gut microbiota, and ovarian cell apoptosis
by: Zhang Yong, et al.
Published: (2024)

The reference value of anti-Müllerian hormone to diagnose polycystic ovary syndrome is inversely associated with BMI: a retrospective study
by: Menghui Zhang, et al.
Published: (2023)

Knockdown of circ-FURIN suppresses the proliferation and induces apoptosis of granular cells in polycystic ovary syndrome via miR-195-5p/BCL2 axis
by: Yongqian Chen, et al.
Published: (2021)

Correlation of AMH with cardiometabolic markers in polycystic ovarian syndrome: Systematic review and meta-analysis
by: Saloni Kamboj, et al.
Published: (2024)

Antioxidant supplements relieve insulin resistance but do not improve lipid metabolism in women with polycystic ovary syndrome: a meta-analysis of randomized clinical trials
by: Ruye Wang, et al.
Published: (2022)

Complications of Obesity in Polycystic Ovary Syndrome: Insulin Resistance and Inflammation
by: Sadaf Saleem Uppal, et al.
Published: (2024)

Anti-mullerian hormone levels before and after ovarian drilling in polycystic ovary syndrome: has this an effect on fertility?
by: Mojgan Javedani Masroor, et al.
Published: (2022)

The relationship between polycystic ovary syndrome and insulin resistance from 1983 to 2022: A bibliometric analysis
by: Tong Chen, et al.
Published: (2022)

BPA and BPS affect the expression of anti-Mullerian hormone (AMH) and its receptor during bovine oocyte maturation and early embryo development
by: Angela Christina Saleh, et al.
Published: (2021)

Age-specific anti-Mullerian hormone (AMH) levels poorly affects cumulative live birth rate after intra-uterine insemination
by: Jessika Moreau, et al.
Published: (2019)

Effect of insulin sensitizers on raised serum anti-mullerian hormone levels in infertile women with polycystic ovarian syndrome
by: Neeti Chhabra, et al.
Published: (2018)

Correlation of anti-Müllerian hormone levels with metabolic syndrome events in polycystic ovary syndrome: A cross-sectional study
by: Budi Wiweko, et al.
Published: (2020)

Age-specific cut-off levels of anti-Müllerian hormone can be used as diagnostic markers for polycystic ovary syndrome
by: Fahimeh Ramezani Tehrani, et al.
Published: (2021)

Examining the oleoylethanolamide supplement effects on glycemic status, oxidative stress, inflammation, and anti-mullerian hormone in polycystic ovary syndrome
by: Fatemeh Taghizadeh Shivyari, et al.
Published: (2024)

Primary Malignant Mixed Müllerian Tumor of the Ovary
by: Chyong-Huey Lai
Published: (2010)

Polycystic Ovary Syndrome, Insulin Resistance, and Obesity: Navigating the Pathophysiologic Labyrinth
by: Joselyn Rojas, et al.
Published: (2014)

The effect of exercise on insulin resistance in obese women with polycystic ovary syndrome
by: Heba S Kareem, et al.
Published: (2014)

Decreased SFRP5 correlated with excessive metabolic inflammation in polycystic ovary syndrome could be reversed by metformin: implication of its role in dysregulated metabolism
by: Yi Zhang, et al.
Published: (2021)